US 10610520
Heterocyclic compound
granted A61KA61K31/407A61K31/4184
Quick answer
US patent 10610520 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/407, A61K31/4184, A61K31/4188, A61K31/422